Multiple low dose therapy as an effective strategy to treat EGFR inhibitor-resistant NSCLC tumours.
Fernandes Neto JM, Nadal E, Bosdriesz E, Ooft SN, Farre L, McLean C, Klarenbeek S, Jurgens A, Hagen H, Wang L, Felip E, Martinez-Marti A, Vidal A, Voest E, Wessels LFA, van Tellingen O, Villanueva A, Bernards R.
Fernandes Neto JM, et al. Among authors: bernards r.
Nat Commun. 2020 Jun 22;11(1):3157. doi: 10.1038/s41467-020-16952-9.
Nat Commun. 2020.
PMID: 32572029
Free PMC article.